90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)
Stopped No patients were enrolled because the company that pledged the drug does not yet have it available.
Conditions
- Neuroblastoma
- Neuroendocrine Tumor
Interventions
- DRUG: Retinoic Acid
- DRUG: Placebo
Sponsor
University of Iowa
Collaborators